Dual effect of lithium on NFAT5 activity in kidney cells

Frontiers in Physiology

Volumn 6, Issue SEP, 2015, Pages

  Küper, Christoph ^a   Beck, Franz Xaver ^a   Neuhofer, Wolfgang ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chronic kidney disease; GSK3 ; Lithium; Nephrogenic diabetes insipidus; NFAT5; Urinary concentrating mechanism

Indexed keywords

BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 70; LITHIUM; NFAT5 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; CONTROLLED STUDY; EMBRYO; ENVIRONMENTAL EXPOSURE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYPEROSMOTIC STRESS; INCUBATION TIME; KIDNEY CELL; OSMOLALITY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 84944751014     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00264     Document Type: Article

References (51)

1. Aida, K., Ikegishi, Y., Chen, J., Tawata, M., Ito, S., Maeda, S., et al. (2000). Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis. Biochem. Biophys. Res. Commun. 277, 281-286. doi: 10.1006/bbrc.2000.3648
2. Aufricht, C., Lu, E., Thulin, G., Kashgarian, M., Siegel, N. J., and Van Why, S. K. (1998). ATP releases HSP-72 from protein aggregates after renal ischemia. Am. J. Physiol. 274, F268-F274.
3. Bao, H., Ge, Y., Wang, Z., Zhuang, S., Dworkin, L., Peng, A., et al. (2014). Delayed administration of a single dose of lithium promotes recovery from AKI. J. Am. Soc. Nephrol. 25, 488-500. doi: 10.1681/ASN.2013040350
4. Behl, T., Kotwani, A., Kaur, I., and Goel, H. (2015). Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus. Eur. J. Pharmacol. 755, 27-33. doi: 10.1016/j.ejphar.2015.02.040
5. Bendz, H., Schön, S., Attman, P. O., and Aurell, M. (2010). Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 77, 219-224. doi: 10.1038/ki.2009.433
6. Birch, N. J., and Hullin, R. P. (1980). Lithium and the kidney. Br. Med. J. 280, 1148-1149. doi: 10.1136/bmj.280.6223.1148-b
7. Blount, M. A., Sim, J. H., Zhou, R., Martin, C. F., Lu, W., Sands, J. M., et al. (2010). Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment. Am. J. Physiol. Renal Physiol. 298, F601-F608. doi: 10.1152/ajprenal.00424.2009
8. Cai, Q., Ferraris, J. D., and Burg, M. B. (2005). High NaCl increases TonEBP/OREBP mRNA and protein by stabilizing its mRNA. Am. J. Physiol. Renal Physiol. 289, F803-F807. doi: 10.1152/ajprenal.00448.2004
9. Costa, J. L., Fay, D. D., Nurnberger, J. I., and Murphy, D. L. (1982). Preferential accumulation of lithium in the dense bodies of human platelets. Biochem. Pharmacol. 31, 3215-3218. doi: 10.1016/0006-2952(82)90552-4
10. Doble, B. W., and Woodgett, J. R. (2003). GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186. doi: 10.1242/jcs.00384
11. Ferraris, J. D., Williams, C. K., Persaud, P., Zhang, Z., Chen, Y., and Burg, M. B. (2002). Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration. Proc. Natl. Acad. Sci. U.S.A. 99, 739-744. doi: 10.1073/pnas.241637298
12. Grünfeld, J. P., and Rossier, B. C. (2009). Lithium nephrotoxicity revisited. Nat. Rev. Nephrol. 5, 270-276. doi: 10.1038/nrneph.2009.43
13. Hasler, U., Jeon, U. S., Kim, J. A., Mordasini, D., Kwon, H. M., Féraille, E., et al. (2006). Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells. J. Am. Soc. Nephrol. 17, 1521-1531. doi: 10.1681/ASN.2005121317
14. Hayslett, J. P., and Kashgarian, M. (1979). A micropuncture study of the renal handling of lithium. Pflugers Arch. 380, 159-163. doi: 10.1007/BF00582152
15. Irarrazabal, C. E., Burg, M. B., Ward, S. G., and Ferraris, J. D. (2006). Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: role in osmoprotective transcriptional regulation. Proc. Natl. Acad. Sci. U.S.A. 103, 8882-8887. doi: 10.1073/pnas.0602911103
16. Ito, T., Fujio, Y., Takahashi, K., and Azuma, J. (2007). Degradation of NFAT5, a transcriptional regulator of osmotic stress-related genes, is a critical event for doxorubicin-induced cytotoxicity in cardiac myocytes. J. Biol. Chem. 282, 1152-1160. doi: 10.1074/jbc.M609547200
17. Kabakov, A. Y., Karkanias, N. B., Lenox, R. H., and Papke, R. L. (1998). Synapse-specific accumulation of lithium in intracellular microdomains: a model for uncoupling coincidence detection in the brain. Synapse 28, 271-279.
18. Kasono, K., Saito, T., Saito, T., Tamemoto, H., Yanagidate, C., Uchida, S., et al. (2005). Hypertonicity regulates the aquaporin-2 promoter independently of arginine vasopressin. Nephrol. Dial. Transplant 20, 509-515. doi: 10.1093/ndt/gfh677
19. Klein, J. D., Gunn, R. B., Roberts, B. R., and Sands, J. M. (2002). Down-regulation of urea transporters in the renal inner medulla of lithium-fed rats. Kidney Int. 61, 995-1002. doi: 10.1046/j.1523-1755.2002.00210.x
20. Klein, P. S., and Melton, D. A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U.S.A. 93, 8455-8459. doi: 10.1073/pnas.93.16.8455
21. Ko, B. C., Lam, A. K., Kapus, A., Fan, L., Chung, S. K., and Chung, S. S. (2002). Fyn and p38 signaling are both required for maximal hypertonic activation of the osmotic response element-binding protein/tonicity-responsive enhancer-binding protein (OREBP/TonEBP). J. Biol. Chem. 277, 46085-46092. doi: 10.1074/jbc.M208138200
22. Ko, B. C., Turck, C. W., Lee, K. W., Yang, Y., and Chung, S. S. (2000). Purification, identification, and characterization of an osmotic response element binding protein. Biochem. Biophys. Res. Commun. 270, 52-61. doi: 10.1006/bbrc.2000.2376
23. Küper, C., Fraek, M. L., Muller, H. H., Beck, F. X., and Neuhofer, W. (2012). Sepsis-induced urinary concentration defect is related to nitric oxide-dependent inactivation of TonEBP/NFAT5, which downregulates renal medullary solute transport proteins and aquaporin-2. Crit. Care Med. 40, 1887-1895. doi: 10.1097/CCM.0b013e31824e1186
24. Kwon, T. H., Laursen, U. H., Marples, D., Maunsbach, A. B., Knepper, M. A., Frokiaer, J., et al. (2000). Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI. Am. J. Physiol. Renal Physiol. 279, F552-F564.
25. Lam, A. K., Ko, B. C., Tam, S., Morris, R., Yang, J. Y., Chung, S. K., et al. (2004). Osmotic response element-binding protein (OREBP) is an essential regulator of the urine concentrating mechanism. J. Biol. Chem. 279, 48048-48054. doi: 10.1074/jbc.M407224200
26. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. doi: 10.1006/meth.2001.1262
27. López-Rodríguez, C., Antos, C. L., Shelton, J. M., Richardson, J. A., Lin, F., Novobrantseva, T. I., et al. (2004). Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc. Natl. Acad. Sci. U.S.A. 101, 2392-2397. doi: 10.1073/pnas.0308703100
28. Markowitz, G. S., Radhakrishnan, J., Kambham, N., Valeri, A. M., Hines, W. H., and D'Agati, V. D. (2000). Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J. Am. Soc. Nephrol. 11, 1439-1448.
29. Marples, D., Christensen, S., Christensen, E. I., Ottosen, P. D., and Nielsen, S. (1995). Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J. Clin. Invest. 95, 1838-1845. doi: 10.1172/JCI117863
30. Mendlewicz, J., Verbanck, P., Linkowski, P., and Wilmotte, J. (1978). Lithium accumulation in erythrocytes of manic-depressive patients: an in vivo twin study. Br. J. Psychiatry 133, 436-444. doi: 10.1192/bjp.133.5.436
31. Miyakawa, H., Woo, S. K., Chen, C. P., Dahl, S. C., Handler, J. S., and Kwon, H. M. (1998). Cis-and trans-acting factors regulating transcription of the BGT1 gene in response to hypertonicity. Am. J. Physiol. 274, F753-F761.
32. Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S., and Kwon, H. M. (1999). Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl. Acad. Sci. U.S.A. 96, 2538-2542. doi: 10.1073/pnas.96.5.2538
33. Nakayama, Y., Peng, T., Sands, J. M., and Bagnasco, S. M. (2000). The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression. J. Biol. Chem. 275, 38275-38280. doi: 10.1074/jbc.M004678200
34. Neuhofer, W., Steinert, D., Fraek, M. L., and Beck, F. X. (2007). Prostaglandin E2 stimulates expression of osmoprotective genes in MDCK cells and promotes survival under hypertonic conditions. J. Physiol. 583, 287-297. doi: 10.1113/jphysiol.2007.135178
35. National Institute for Health and Care Excellence, (NICE) (2006). "Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care," in Clinical Guideline 38.
36. Nielsen, J., Hoffert, J. D., Knepper, M. A., Agre, P., Nielsen, S., and Fenton, R. A. (2008). Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation. Proc. Natl. Acad. Sci. U.S.A. 105, 3634-3639. doi: 10.1073/pnas.0800001105
37. Plotnikov, E. Y., Grebenchikov, O. A., Babenko, V. A., Pevzner, I. B., Zorova, L. D., Likhvantsev, V. V., et al. (2013). Nephroprotective effect of GSK-3beta inhibition by lithium ions and delta-opioid receptor agonist dalargin on gentamicin-induced nephrotoxicity. Toxicol. Lett. 220, 303-308. doi: 10.1016/j.toxlet.2013.04.023
38. Presne, C., Fakhouri, F., Noël, L. H., Stengel, B., Even, C., Kreis, H., et al. (2003). Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int. 64, 585-592. doi: 10.1046/j.1523-1755.2003.00096.x
39. Quadri, S., and Siragy, H. M. (2014). Regulation of (pro)renin receptor expression in mIMCD via the GSK-3beta-NFAT5-SIRT-1 signaling pathway. Am. J. Physiol. Renal Physiol. 307, F593-F600. doi: 10.1152/ajprenal.00245.2014
40. Roth, I., Leroy, V., Kwon, H. M., Martin, P. Y., Féraille, E., and Hasler, U. (2010). Osmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity. Mol. Biol. Cell 21, 3459-3474. doi: 10.1091/mbc.E10-02-0133
41. Stambolic, V., Ruel, L., and Woodgett, J. R. (1996). Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6, 1664-1668. doi: 10.1016/S0960-9822(02)70790-2
42. Talab, S. S., Elmi, A., Emami, H., Nezami, B. G., Assa, S., Ghasemi, M., et al. (2012). Protective effects of acute lithium preconditioning against renal ischemia/reperfusion injury in rat: role of nitric oxide and cyclooxygenase systems. Eur. J. Pharmacol. 681, 94-99. doi: 10.1016/j.ejphar.2012.01.042
43. Talab, S. S., Emami, H., Elmi, A., Nezami, B. G., Assa, S., Deroee, A. F., et al. (2010). Chronic lithium treatment protects the rat kidney against ischemia/reperfusion injury: the role of nitric oxide and cyclooxygenase pathways. Eur. J. Pharmacol. 647, 171-177. doi: 10.1016/j.ejphar.2010.08.036
44. Thomas, R. C., Simon, W., and Oehme, M. (1975). Lithium accumulation by snail neurones measured by a new Li+-sensitive microelectrode. Nature 258, 754-756. doi: 10.1038/258754a0
45. Umekita, K., Trenkmann, M., Kolling, C., Michel, B. A., Gay, R. E., Gay, S., et al. (2013). Long noncoding RNA Nron regulates the cytoplasmic-nuclear shuttling and activity of NFAT5 in rheumatoid arthritis synovial fibroblast [Abstract]. Arthritis Rheum. 65(Suppl. 10):2872. doi: 10.1002/art.2013.65.issue-s10
46. Wang, Y., Huang, W. C., Wang, C. Y., Tsai, C. C., Chen, C. L., Chang, Y. T., et al. (2009). Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis. Br. J. Pharmacol. 157, 1004-1013. doi: 10.1111/j.1476-5381.2009.00284.x
47. Wang, Z., Gall, J. M., Bonegio, R. G., Havasi, A., Hunt, C. R., Sherman, M. Y., et al. (2011). Induction of heat shock protein 70 inhibits ischemic renal injury. Kidney Int. 79, 861-870. doi: 10.1038/ki.2010.527
48. Woo, S. K., Lee, S. D., Na, K. Y., Park, W. K., and Kwon, H. M. (2002). TonEBP/NFAT5 stimulates transcription of HSP70 in response to hypertonicity. Mol. Cell. Biol. 22, 5753-5760. doi: 10.1128/MCB.22.16.5753-5760.2002
49. Yeh, C. H., Hsu, S. P., Yang, C. C., Chien, C. T., and Wang, N. P. (2010). Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy. Life Sci. 86, 115-123. doi: 10.1016/j.lfs.2009.11.022
50. Zhang, Z., Ferraris, J. D., Brooks, H. L., Brisc, I., and Burg, M. B. (2003). Expression of osmotic stress-related genes in tissues of normal and hyposmotic rats. Am. J. Physiol. Renal Physiol. 285, F688-F693. doi: 10.1152/ajprenal.00028.2003
51. Zhou, X., Wang, H., Burg, M. B., and Ferraris, J. D. (2013). Inhibitory phosphorylation of GSK-3beta by AKT, PKA, and PI3K contributes to high NaCl-induced activation of the transcription factor NFAT5 (TonEBP/OREBP). Am. J. Physiol. Renal Physiol. 304, F908-F917. doi: 10.1152/ajprenal.00591.2012